Additionally, the general neuroprotective mechanisms of GLP-1 RAs could be extended to other ND areas, such as ALS, HD, and frontotemporal dementia, where some ancillary evidence of benefit exists [9]. The gene discussed is GCG; the disease is Huntington disease.